{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:42:59Z","timestamp":1789684979432,"version":"4.0.1"},"reference-count":14,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.5858\/arpa.2015-0508-le","type":"journal-article","created":{"date-parts":[[2016,4,29]],"date-time":"2016-04-29T16:37:50Z","timestamp":1461947870000},"page":"391","source":"Crossref","is-referenced-by-count":20,"title":["Immunohistochemistry for NF2, LATS1\/2, and YAP\/TAZ Fails to Separate Benign From Malignant Mesothelial Proliferations"],"prefix":"10.5858","volume":"140","author":[{"given":"Brandon S.","family":"Sheffield","sequence":"first","affiliation":[{"name":"Departments of Pathology and Laboratory Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Lorette","sequence":"additional","affiliation":[{"name":"Department of Pathology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaoqing","family":"Shen","sequence":"additional","affiliation":[{"name":"Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco A.","family":"Marra","sequence":"additional","affiliation":[{"name":"Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, Canada;"},{"name":"Medical Genetics, University of British Columbia, Vancouver, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Churg","sequence":"additional","affiliation":[{"name":"Departments of Pathology and Laboratory Medicine and"},{"name":"Department of Pathology, Vancouver General Hospital, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3906","reference":[{"issue":"7","key":"i1543-2165-140-5-391a-b01","series-title":"Am J Surg Pathol","first-page":"977","article-title":"BAP1 immunohistochemistry and p16 FISH to separate benign from malignant mesothelial proliferations","volume":"39","author":"Sheffield \n              BS,","year":"2015","unstructured":"Sheffield \n              BS, \n            \n            \n              Hwang \n              HC, \n            \n            \n              Lee \n              AF, \n            \n            et al\n          . BAP1 immunohistochemistry and p16 FISH to separate benign from malignant mesothelial proliferations. Am J Surg Pathol. 2015;39(7):977\u2013982."},{"issue":"4","key":"i1543-2165-140-5-391a-b02","series-title":"Arch Pathol Lab Med","first-page":"318","article-title":"New markers for separating benign from malignant mesothelial proliferations: are we there yet?","volume":"140","author":"Churg \n              A,","year":"2016","unstructured":"Churg \n              A, \n            \n            \n              Sheffield \n              BS, \n            \n            \n              Galateau-Salle \n              F. \n            \n          \n          New markers for separating benign from malignant mesothelial proliferations: are we there yet?\n          Arch Pathol Lab Med. 2016;140(4):318\u2013321."},{"issue":"5","key":"i1543-2165-140-5-391a-b03","series-title":"J Thorac Oncol","first-page":"844","article-title":"Hippo pathway gene mutations in malignant mesothelioma: revealed by RNA and targeted exon sequencing","volume":"10","author":"Miyanaga \n              A,","year":"2015","unstructured":"Miyanaga \n              A, \n            \n            \n              Masuda \n              M, \n            \n            \n              Tsuta \n              K, \n            \n            et al. \n          Hippo pathway gene mutations in malignant mesothelioma: revealed by RNA and targeted exon sequencing. J Thorac Oncol. 2015;10(5):844\u2013851."},{"issue":"2","key":"i1543-2165-140-5-391a-b04","series-title":"Cancer Res","first-page":"264","article-title":"Whole-exome sequencing reveals frequent genetic alterations in BAP1, NF2, CDKN2A, and CUL1 in malignant pleural mesothelioma","volume":"75","author":"Guo \n              G,","year":"2015","unstructured":"Guo \n              G, \n            \n            \n              Chmielecki \n              J, \n            \n            \n              Goparaju \n              C, \n            \n            et al. \n          Whole-exome sequencing reveals frequent genetic alterations in BAP1, NF2, CDKN2A, and CUL1 in malignant pleural mesothelioma. Cancer Res. 2015;75(2):264\u2013269."},{"issue":"1","key":"i1543-2165-140-5-391a-b05","series-title":"Mod Pathol","first-page":"14","article-title":"The prognostic significance of BAP1, NF2, and CDKN2A in malignant peritoneal mesothelioma","volume":"29","author":"Singhi \n              AD,","year":"2016","unstructured":"Singhi \n              AD, \n            \n            \n              Krasinskas \n              AM, \n            \n            \n              Chourdy \n              HA, \n            \n            et al. \n          The prognostic significance of BAP1, NF2, and CDKN2A in malignant peritoneal mesothelioma. Mod Pathol. 2016;29(1):14\u201324."},{"issue":"4","key":"i1543-2165-140-5-391a-b06","series-title":"Cell","first-page":"811","article-title":"Hippo pathway in organ size control, tissue homeostasis, and cancer","volume":"163","author":"Yu \n              FX,","year":"2015","unstructured":"Yu \n              FX, \n            \n            \n              Zhao \n              B, \n            \n            \n              Guan \n              KL. \n            \n          \n          Hippo pathway in organ size control, tissue homeostasis, and cancer. Cell. 2015;163(4):811\u2013828."},{"issue":"3","key":"i1543-2165-140-5-391a-b07","series-title":"PLoS One","first-page":"e0119689","article-title":"Personalized oncogenomics: clinical experience with malignant peritoneal mesothelioma using whole genome sequencing","volume":"10","author":"Sheffield \n              BS,","year":"2015","unstructured":"Sheffield \n              BS, \n            \n            \n              Tinker \n              AV, \n            \n            \n              Shen \n              Y, \n            \n            et al. \n          Personalized oncogenomics: clinical experience with malignant peritoneal mesothelioma using whole genome sequencing. PLoS One. 2015;10(3):e0119689."},{"issue":"7","key":"i1543-2165-140-5-391a-b01","series-title":"Am J Surg Pathol","first-page":"977","article-title":"BAP1 immunohistochemistry and p16 FISH to separate benign from malignant mesothelial proliferations","volume":"39","author":"Sheffield \n              BS,","year":"2015","unstructured":"Sheffield \n              BS, \n            \n            \n              Hwang \n              HC, \n            \n            \n              Lee \n              AF, \n            \n            et al\n          . BAP1 immunohistochemistry and p16 FISH to separate benign from malignant mesothelial proliferations. Am J Surg Pathol. 2015;39(7):977\u2013982."},{"issue":"4","key":"i1543-2165-140-5-391a-b02","series-title":"Arch Pathol Lab Med","first-page":"318","article-title":"New markers for separating benign from malignant mesothelial proliferations: are we there yet?","volume":"140","author":"Churg \n              A,","year":"2016","unstructured":"Churg \n              A, \n            \n            \n              Sheffield \n              BS, \n            \n            \n              Galateau-Salle \n              F. \n            \n          \n          New markers for separating benign from malignant mesothelial proliferations: are we there yet?\n          Arch Pathol Lab Med. 2016;140(4):318\u2013321."},{"issue":"5","key":"i1543-2165-140-5-391a-b03","series-title":"J Thorac Oncol","first-page":"844","article-title":"Hippo pathway gene mutations in malignant mesothelioma: revealed by RNA and targeted exon sequencing","volume":"10","author":"Miyanaga \n              A,","year":"2015","unstructured":"Miyanaga \n              A, \n            \n            \n              Masuda \n              M, \n            \n            \n              Tsuta \n              K, \n            \n            et al. \n          Hippo pathway gene mutations in malignant mesothelioma: revealed by RNA and targeted exon sequencing. J Thorac Oncol. 2015;10(5):844\u2013851."},{"issue":"2","key":"i1543-2165-140-5-391a-b04","series-title":"Cancer Res","first-page":"264","article-title":"Whole-exome sequencing reveals frequent genetic alterations in BAP1, NF2, CDKN2A, and CUL1 in malignant pleural mesothelioma","volume":"75","author":"Guo \n              G,","year":"2015","unstructured":"Guo \n              G, \n            \n            \n              Chmielecki \n              J, \n            \n            \n              Goparaju \n              C, \n            \n            et al. \n          Whole-exome sequencing reveals frequent genetic alterations in BAP1, NF2, CDKN2A, and CUL1 in malignant pleural mesothelioma. Cancer Res. 2015;75(2):264\u2013269."},{"issue":"1","key":"i1543-2165-140-5-391a-b05","series-title":"Mod Pathol","first-page":"14","article-title":"The prognostic significance of BAP1, NF2, and CDKN2A in malignant peritoneal mesothelioma","volume":"29","author":"Singhi \n              AD,","year":"2016","unstructured":"Singhi \n              AD, \n            \n            \n              Krasinskas \n              AM, \n            \n            \n              Chourdy \n              HA, \n            \n            et al. \n          The prognostic significance of BAP1, NF2, and CDKN2A in malignant peritoneal mesothelioma. Mod Pathol. 2016;29(1):14\u201324."},{"issue":"4","key":"i1543-2165-140-5-391a-b06","series-title":"Cell","first-page":"811","article-title":"Hippo pathway in organ size control, tissue homeostasis, and cancer","volume":"163","author":"Yu \n              FX,","year":"2015","unstructured":"Yu \n              FX, \n            \n            \n              Zhao \n              B, \n            \n            \n              Guan \n              KL. \n            \n          \n          Hippo pathway in organ size control, tissue homeostasis, and cancer. Cell. 2015;163(4):811\u2013828."},{"issue":"3","key":"i1543-2165-140-5-391a-b07","series-title":"PLoS One","first-page":"e0119689","article-title":"Personalized oncogenomics: clinical experience with malignant peritoneal mesothelioma using whole genome sequencing","volume":"10","author":"Sheffield \n              BS,","year":"2015","unstructured":"Sheffield \n              BS, \n            \n            \n              Tinker \n              AV, \n            \n            \n              Shen \n              Y, \n            \n            et al. \n          Personalized oncogenomics: clinical experience with malignant peritoneal mesothelioma using whole genome sequencing. PLoS One. 2015;10(3):e0119689."}],"container-title":["Archives of Pathology & Laboratory Medicine"],"original-title":[],"link":[{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/140\/5\/article-p391_2.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/140\/5\/391\/1445984\/arpa_2015-0508-le.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aplm.kglmeridian.com\/downloadpdf\/journals\/arpa\/140\/5\/article-p391_2.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aplm.kglmeridian.com\/downloadpdf\/journals\/arpa\/140\/5\/article-p391_2.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T01:07:37Z","timestamp":1770772057000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/140\/5\/article-p391_2.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":14,"journal-issue":{"issue":"5"},"URL":"https:\/\/doi.org\/10.5858\/arpa.2015-0508-le","relation":{},"ISSN":["1543-2165","0003-9985"],"issn-type":[{"value":"1543-2165","type":"electronic"},{"value":"0003-9985","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]}}}